Skip to content

Standard Follow-Up Program (SFP) for Patients With Esophageal Cancer

Standard Follow-up Program (SFP) for Esophageal Cancer Patients Treated With Radiotherapy or Chemoradiation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02454790
Acronym
SFP OES
Enrollment
10000
Registered
2015-05-27
Start date
2014-09-30
Completion date
2030-01-31
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Keywords

Acute toxicity, Late toxicity, Prediction models

Brief summary

Motive: In order to improve the treatment technique, a comprehensive follow-up program is needed to obtain all relevant patient, treatment and toxicity data from esophageal cancer patients. Goal: To set-up and maintain a database containing treatment results in terms of tumor control, side effects, complications and patient-reported quality of life. A standard database of patients receiving photon treatment will be created. These data are then linked to dose-volume data of radiotherapy, with the aim to build prediction models for both tumor control and toxicity after radio (chemo) therapy that can later be used for selecting patients for proton treatment.

Interventions

RADIATIONRadiotherapy

Sponsors

University Medical Center Groningen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with esophageal cancer * Patients receiving a radiotherapy dose \> 40 Gy

Exclusion criteria

* Failure to comply with any of the inclusion criteria

Design outcomes

Primary

MeasureTime frame
Acute toxicityHighest during and within 2 weeks after last day of radiation therapy
Late toxicityHighest within one year after last day of radiation therapy

Secondary

MeasureTime frame
Overall survivalAt 1,2,3,4 and 5 years after first day of radiation therapy
Loco-regional tumor controlAt 1,2,3,4 and 5 years after first day of radiation therapy

Other

MeasureTime frame
Patient-rated symptoms and Quality-of-LifeBefore first day of radiation therapy and at 3,6,12,24,36,48,60 months after first day of radiation therapy

Countries

Netherlands

Contacts

Primary ContactCT Muijs, MD PhD
c.t.muijs@umcg.nl+31503615179

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026